JUVENILE IDIOPATHIC ARTHRITIS

[1]  C. Klersy,et al.  Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis. , 2009, Arthritis and rheumatism.

[2]  A. Martini,et al.  Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis , 2009, Arthritis research & therapy.

[3]  W. Kuis,et al.  Systemic JIA: new developments in the understanding of the pathophysiology and therapy. , 2009, Best practice & research. Clinical rheumatology.

[4]  P. Woo,et al.  An overview of genetics of paediatric rheumatic diseases. , 2009, Best practice & research. Clinical rheumatology.

[5]  S. Albani,et al.  Using biology of disease to understand and guide therapy of JIA. , 2009, Best practice & research. Clinical rheumatology.

[6]  P. Woo.  Theoretical and practical basis for early aggressive therapy in paediatric autoimmune disorders , 2009, Current opinion in rheumatology.

[7]  N. Wulffraat,et al.  Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. , 2009, Arthritis and rheumatism.

[8]  K. Minden,et al.  The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database. , 2009, Clinical and experimental rheumatology.

[9]  E. Haddad,et al.  Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. , 2009, Arthritis and rheumatism.

[10]  Paul Pavlidis,et al.  Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets. , 2009, Arthritis and rheumatism.

[11]  Lukasz Itert,et al.  Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. , 2009, Arthritis and rheumatism.

[12]  J. Soep,et al.  Anakinra for Systemic Juvenile Arthritis: The Rocky Mountain Experience , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[13]  S. Kamphuis,et al.  Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new? , 2009, Arthritis research & therapy.

[14]  Alberto Martini,et al.  Development and validation of a composite disease activity score for juvenile idiopathic arthritis. , 2009, Arthritis and rheumatism.

[15]  Seth L Masters,et al.  Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). , 2009, Annual review of immunology.

[16]  D. Foell,et al.  The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. , 2009, Arthritis and rheumatism.

[17]  C. Wallace,et al.  Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis , 2009, Arthritis research & therapy.

[18]  I. Foeldvari,et al.  Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry , 2008, Annals of the rheumatic diseases.

[19]  E. Hoppenreijs,et al.  Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register , 2008, Annals of the rheumatic diseases.

[20]  A. Górska,et al.  Impairment of microcirculation in juvenile idiopathic arthritis - studies by nailfold videocapillaroscopy and correlation with serum levels of sICAM and VEGF. , 2009, Folia histochemica et cytobiologica.

[21]  M. Valle,et al.  Magnetic resonance imaging, ultrasonography, and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis. , 2008, Arthritis and rheumatism.

[22]  Mohsen Sadatsafavi,et al.  Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. , 2008, Arthritis and rheumatism.

[23]  M. Ehrenstein,et al.  Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis , 2008, Proceedings of the National Academy of Sciences.

[24]  Bin Huang,et al.  Biochemical markers of bone turnover associated with calcium supplementation in children with juvenile rheumatoid arthritis: results of a double-blind, placebo-controlled intervention trial. , 2008, Arthritis and rheumatism.

[25]  A. Martini,et al.  Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sample. , 2008, Arthritis and rheumatism.

[26]  A. Ramanan,et al.  A case of macrophage activation syndrome successfully treated with anakinra , 2008, Nature Clinical Practice Rheumatology.

[27]  D. Glass,et al.  Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. , 2008, Arthritis and rheumatism.

[28]  K. Minden,et al.  Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. , 2008, The New England journal of medicine.

[29]  A. Martini,et al.  Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. , 2008, Arthritis and rheumatism.

[30]  A. Martini,et al.  Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial , 2008, The Lancet.

[31]  L. Hartling,et al.  Children Are Not Just Small Adults: The Urgent Need for High-Quality Trial Evidence in Children , 2008, PLoS medicine.

[32]  Sampath Prahalad,et al.  A comprehensive review of the genetics of juvenile idiopathic arthritis , 2008, Pediatric rheumatology online journal.

[33]  Virginia Pascual,et al.  How the study of children with rheumatic diseases identified interferon‐α and interleukin‐1 as novel therapeutic targets , 2008, Immunological reviews.

[34]  C. Lewis,et al.  Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis , 2008, Genes and Immunity.

[35]  A. Reiff,et al.  Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[36]  A. Martini,et al.  The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. , 2008, Arthritis and rheumatism.

[37]  T. Kishimoto,et al.  Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial , 2008, The Lancet.

[38]  L. Wedderburn,et al.  Interleukin-17–producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers , 2008, Arthritis and rheumatism.

[39]  M. Arbogast.  Sport bei Rheuma und Gelenkersatz , 2008 .

[40]  M. Gattinara,et al.  Focus on adverse events of tumour necrosis factor α blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients , 2007, Annals of the rheumatic diseases.

[41]  J. Roth,et al.  New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment. , 2007, Rheumatology.

[42]  J. Sibilia,et al.  Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France , 2007, Annals of the rheumatic diseases.

[43]  R. Sundel,et al.  Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis. , 2008, Arthritis and rheumatism.

[44]  Sherry Thornton,et al.  Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. , 2007, Arthritis and rheumatism.

[45]  V. Pascual,et al.  Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade , 2007, The Journal of experimental medicine.

[46]  A. Martini,et al.  Adapted versions of the Sharp/van der Heijde score are reliable and valid for assessment of radiographic progression in juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.

[47]  A. Fischer,et al.  Immunotherapy of Familial Hemophagocytic Lymphohistiocytosis With Antithymocyte Globulins: A Single-Center Retrospective Report of 38 Patients , 2007, Pediatrics.

[48]  T. Lehman.  The future of pediatric rheumatology: many questions remain. , 2007, Arthritis and rheumatism.

[49]  C. Wouters,et al.  A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[50]  A. Martini,et al.  Development and validation of a new short and simple measure of physical function for juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.

[51]  J. Taurog.  The mystery of HLA-B27: if it isn't one thing, it's another. , 2007, Arthritis and rheumatism.

[52]  D. Teachey,et al.  Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis. , 2007, Journal of pediatric hematology/oncology.

[53]  R. Cate,et al.  Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. , 2007, Arthritis and rheumatism.

[54]  R. Saurenmann,et al.  Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. , 2007, Arthritis and rheumatism.

[55]  Paul Kellam,et al.  Specific gene expression profiles in systemic juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.

[56]  A. Zwinderman,et al.  Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment , 2007, Annals of the rheumatic diseases.

[57]  A. Sette,et al.  Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.

[58]  C. Acar,et al.  Valve repair for mitral insufficiency secondary to idiopathic juvenile polyarthritis. , 2007, The Journal of heart valve disease.

[59]  R. Cron,et al.  Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. , 2007, The Journal of rheumatology.

[60]  W. Thomson,et al.  Positive association of SLC26A2 gene polymorphisms with susceptibility to systemic-onset juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.

[61]  E. Neufeld,et al.  Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases. , 2007, The Journal of pediatrics.

[62]  S. Kirschner,et al.  Ergebnisse endoprothetischer Versorgung bei Patienten vor dem 50. Lebensjahr , 2007, Der Orthopäde.

[63]  R. Forst,et al.  Indikationen und Alternativen der endoprothetischen Versorgung beim jüngeren Patienten , 2007, Der Orthopäde.

[64]  A. Ramanan,et al.  The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.

[65]  E. Hoppenreijs,et al.  Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis , 2007, Annals of the rheumatic diseases.

[66]  A. Hoes,et al.  Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.

[67]  R. Saurenmann,et al.  Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. , 2007, Arthritis and rheumatism.

[68]  M. Aricò,et al.  HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis , 2007, Pediatric blood & cancer.

[69]  H. Hamm,et al.  Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis , 2007, Arthritis research & therapy.

[70]  M. Ehrenstein,et al.  Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β , 2007, The Journal of experimental medicine.

[71]  E. Hoppenreijs,et al.  Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study , 2006, Annals of the rheumatic diseases.

[72]  M. Sormani,et al.  Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration. , 2006, Rheumatology.

[73]  G. Janka.  Familial and acquired hemophagocytic lymphohistiocytosis. , 2007, European journal of pediatrics.

[74]  R. Saurenmann,et al.  Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents. , 2006, The Journal of pediatrics.

[75]  D. Zurakowski,et al.  Patients with juvenile psoriatic arthritis comprise two distinct populations. , 2006, Arthritis and rheumatism.

[76]  M. Valle,et al.  Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. , 2006, Arthritis and rheumatism.

[77]  Yasmin,et al.  Rheumatoid Arthritis Is Associated With Increased Aortic Pulse-Wave Velocity, Which Is Reduced by Anti–Tumor Necrosis Factor-&agr; Therapy , 2006, Circulation.

[78]  C. Lewis,et al.  Novel IL10 gene family associations with systemic juvenile idiopathic arthritis , 2006, Arthritis research & therapy.

[79]  R. Saurenmann,et al.  Tumour necrosis factor α inhibitors in the treatment of childhood uveitis , 2006 .

[80]  Bin Huang,et al.  A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[81]  R. Schneider,et al.  Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[82]  S. Kamphuis,et al.  Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis , 2006, Expert opinion on biological therapy.

[83]  R. Schneider,et al.  Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. , 2006, Arthritis and rheumatism.

[84]  J. Bolognese,et al.  Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension. , 2006, The Journal of rheumatology.

[85]  Carol A Wallace,et al.  Current management of juvenile idiopathic arthritis. , 2006, Best practice & research. Clinical rheumatology.

[86]  L. Wedderburn,et al.  Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells , 2006, Arthritis research & therapy.

[87]  H. Morbach,et al.  Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis , 2006, Annals of the rheumatic diseases.

[88]  N. Wulffraat,et al.  Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. , 2006, Blood.

[89]  H. Michels,et al.  Zertifizierte Fortbildung: Gelenkerhaltende Therapie des Ellenbogenbefalls bei der juvenilen idiopathischen Arthritis , 2006 .

[90]  S. Albani,et al.  T cell epitope-specific immune therapy for rheumatic diseases. , 2006, Arthritis and rheumatism.

[91]  P. Babyn,et al.  Radiologic investigation of rheumatic diseases. , 2007, Pediatric clinics of North America.

[92]  C. Dinarello,et al.  Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. , 2005, Blood.

[93]  Bin Huang,et al.  Patterns of clinical remission in select categories of juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.

[94]  R. Laxer,et al.  Medical treatment of juvenile idiopathic arthritis. , 2005, JAMA.

[95]  P. Manners,et al.  Infliximab for juvenile idiopathic arthritis‐associated uveitis , 2005, Clinical & experimental ophthalmology.

[96]  M. Dougados,et al.  Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. , 2005, The New England journal of medicine.

[97]  A. Martini,et al.  Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis. , 2005, The Journal of rheumatology.

[98]  D. Kastner,et al.  Familial autoinflammatory diseases: genetics, pathogenesis and treatment , 2005, Current opinion in rheumatology.

[99]  A. Zwinderman,et al.  Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score. , 2005, Arthritis and rheumatism.

[100]  B. Dardzinski,et al.  Quantitative magnetic resonance imaging of the hands and wrists of children with juvenile rheumatoid arthritis. , 2005, The Journal of rheumatology.

[101]  G. Horneff,et al.  Etanercept and uveitis in patients with juvenile idiopathic arthritis. , 2005, Rheumatology.

[102]  A. Sette,et al.  Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis , 2005, The Lancet.

[103]  R. Burgos-Vargas,et al.  Anti–tumor necrosis factor α blockade in the treatment of juvenile spondylarthropathy , 2005 .

[104]  A. Martini,et al.  Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.

[105]  K. Gauvreau,et al.  Coronary Artery Dilation Among Patients Presenting With Systemic-Onset Juvenile Idiopathic Arthritis , 2005, Pediatrics.

[106]  T. Takken,et al.  Physiologic response of the six-minute walk test in children with juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.

[107]  F. Sallusto,et al.  Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia , 2005, The Journal of experimental medicine.

[108]  Wendy Thomson,et al.  Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. , 2005, Arthritis and rheumatism.

[109]  V. Pascual,et al.  Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade , 2005, The Journal of experimental medicine.

[110]  A. Reiff,et al.  Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis. , 2005, The Journal of rheumatology.

[111]  A. Martini,et al.  Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. , 2005, The Journal of pediatrics.

[112]  N. Ilowite,et al.  Response of systemic onset juvenile rheumatoid arthritis to etanercept: is the glass half full or half empty? , 2005, The Journal of rheumatology.

[113]  R. Saurenmann,et al.  Leflunomide or methotrexate for juvenile rheumatoid arthritis. , 2005, The New England journal of medicine.

[114]  B. Prakken,et al.  Heat-shock proteins induce T-cell regulation of chronic inflammation , 2005, Nature Reviews Immunology.

[115]  P Woo,et al.  PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it , 2005, Annals of the rheumatic diseases.

[116]  A. Martini,et al.  Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. , 2005, Arthritis and rheumatism.

[117]  P. Woo,et al.  Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.

[118]  A. Martini,et al.  Inherited autoinflammatory syndromes: an expanding new group of chronic inflammatory diseases. , 2005, Clinical and experimental rheumatology.

[119]  T. Egeland,et al.  A two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.

[120]  A. Martini,et al.  Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis? , 2005, Arthritis and rheumatism.

[121]  Jonghyeon Kim,et al.  A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.

[122]  C. Wouters,et al.  Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages. , 2005, Blood.

[123]  A. Prieur,et al.  A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results. , 2005, Arthritis and rheumatism.

[124]  V. Strand,et al.  Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[125]  A. Martini,et al.  Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis , 2005, Arthritis research & therapy.

[126]  Tae-Hwan Kim,et al.  Pathogenesis of ankylosing spondylitis and reactive arthritis , 1994, Current opinion in rheumatology.

[127]  C. Wouters,et al.  Comparison of safety, efficacy and pharmacokinetics for 3 and 6 mg/kg infliximab plus methotrexate therapy in JRA patients , 2005 .

[128]  M. Rewers,et al.  Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[129]  Sampath Prahalad,et al.  Familial aggregation of juvenile idiopathic arthritis. , 2004, Arthritis and rheumatism.

[130]  D. Foell,et al.  Proinflammatory S100 proteins in arthritis and autoimmune disease. , 2004, Arthritis and rheumatism.

[131]  R. Sundel,et al.  Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study. , 2004, The Journal of pediatrics.

[132]  G. Firestein,et al.  Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist , 2004, The Lancet.

[133]  E. Giannini,et al.  Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. , 2004, The Journal of rheumatology.

[134]  S Gary Firestein,et al.  Kelley's Textbook of Rheumatology , 2004 .

[135]  A. Reiff,et al.  Prolonged efficacy of etanercept in refractory enthesitis-related arthritis. , 2004, The Journal of rheumatology.

[136]  J. Verbsky,et al.  Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. , 2004, The Journal of rheumatology.

[137]  N. Sinha,et al.  Assessment of left ventricular systolic and diastolic function in juvenile rheumatoid arthritis. , 2004, Journal of postgraduate medicine.

[138]  P. Manners,et al.  Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. , 2004, Rheumatology.

[139]  N. Wulffraat,et al.  Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity , 2004, Annals of the rheumatic diseases.

[140]  S. Bae,et al.  The PRINTO /PRES international website for families of children with rheumatic diseases , 2004 .

[141]  Sampath Prahalad,et al.  A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage. , 2004, Arthritis and rheumatism.

[142]  Sampath Prahalad,et al.  Genetics of juvenile idiopathic arthritis: an update , 2004, Current opinion in rheumatology.

[143]  O. Kasapcopur,et al.  Cardiopulmonary exercise testing in juvenile idiopathic arthritis. , 2004, The Journal of rheumatology.

[144]  A. Martini,et al.  International research networks in pediatric rheumatology: the PRINTO perspective , 2004, Current opinion in rheumatology.

[145]  A. Martini,et al.  Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis. , 2004, Rheumatology.

[146]  R. Saurenmann,et al.  A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. , 2004, Arthritis and rheumatism.

[147]  S. Sarna,et al.  Growth hormone is effective in the treatment of severe growth retardation in children with juvenile chronic arthritis. Double blind placebo-controlled followup study. , 2004, The Journal of rheumatology.

[148]  H. Oda,et al.  Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome. , 2004, Arthritis and rheumatism.

[149]  D. Glass,et al.  Juvenile rheumatoid arthritis affected sibpairs: extent of clinical phenotype concordance. , 2004, Arthritis and rheumatism.

[150]  W. Kuis,et al.  CD4+CD25bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients with the Remitting Form of Juvenile Idiopathic Arthritis , 2004, The Journal of Immunology.

[151]  E. Zeggini,et al.  A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. , 2004, Arthritis and rheumatism.

[152]  A Ravelli,et al.  Toward an understanding of the long-term outcome of juvenile idiopathic arthritis. , 2004, Clinical and experimental rheumatology.

[153]  R. Shamir,et al.  Assessment of osteoporosis by quantitative ultrasound versus dual energy X-ray absorptiometry in children with chronic rheumatic diseases. , 2004, The Journal of rheumatology.

[154]  Elizabeta Nemeth,et al.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. , 2004, The Journal of clinical investigation.

[155]  I. Foeldvari,et al.  The German etanercept registry for treatment of juvenile idiopathic arthritis , 2004, Annals of the rheumatic diseases.

[156]  W. Kuis,et al.  Safety of anti-TNFalpha therapy in children with juvenile idiopathic arthritis. , 2004, Clinical and experimental rheumatology.

[157]  D. Foell,et al.  Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. , 2004, Arthritis and rheumatism.

[158]  S. Kamphuis,et al.  Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis. , 2004, Rheumatology.

[159]  A. Grom.  Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? , 2004, Arthritis and rheumatism.

[160]  M. Suarez‐Almazor,et al.  International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .

[161]  R. Colbert.  The immunobiology of HLA-B27: variations on a theme. , 2004, Current molecular medicine.

[162]  D. Foell,et al.  Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? , 2004, Annals of the rheumatic diseases.

[163]  A. Bakkaloğlu,et al.  Mitral and aortic insufficiency in polyarticular juvenile rheumatoid arthritis , 1994, Pediatric Cardiology.

[164]  R. Petty,et al.  The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate. , 2004, The Journal of rheumatology.

[165]  R. Misra,et al.  Juvenile chronic arthritis in India: is it different from that seen in Western countries? , 2004, Rheumatology International.

[166]  W. Puhl,et al.  Semiarthroscopic synovectomy of the hip , 2004, International Orthopaedics.

[167]  A. Martini,et al.  Prognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritis. , 2003, Arthritis and rheumatism.

[168]  S. Fisher,et al.  The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. , 2003, Arthritis and rheumatism.

[169]  M. Argyropoulou,et al.  Distensibility and pulse wave velocity of the thoracic aorta in patients with juvenile idiopathic arthritis: an MRI study. , 2003, Clinical and experimental rheumatology.

[170]  S. Bechtold,et al.  Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study. , 2003, The Journal of pediatrics.

[171]  Liem Jj,et al.  Growth patterns in juvenile rheumatoid arthritis. , 2003 .

[172]  A. Martini.  Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis? , 2003, The Journal of rheumatology.

[173]  D. Glass,et al.  Non-HLA gene polymorphisms in juvenile rheumatoid arthritis. , 2003, Clinical and experimental rheumatology.

[174]  A. Martini,et al.  Early predictors of outcome in juvenile idiopathic arthritis. , 2003, Clinical and experimental rheumatology.

[175]  A. Martini,et al.  Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis. , 2003, Arthritis and rheumatism.

[176]  T. Egeland,et al.  Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients. , 2003, Arthritis and rheumatism.

[177]  J. Marini.  Do bisphosphonates make children's bones better or brittle? , 2003, The New England journal of medicine.

[178]  S. Kamphuis,et al.  The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. , 2003, Arthritis and rheumatism.

[179]  Justine R. Smith,et al.  Arthritis and uveitis in children. A pediatric rheumatology perspective. , 2003, American journal of ophthalmology.

[180]  W. Thomson,et al.  Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. , 2003, Arthritis and rheumatism.

[181]  A. Zwinderman,et al.  Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. , 2003, The Journal of rheumatology.

[182]  A. Prieur,et al.  Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. , 2003, Arthritis and rheumatism.

[183]  A. Zwinderman,et al.  Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method. , 2003, Arthritis and rheumatism.

[184]  N. Wulffraat,et al.  Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. , 2003, Rheumatology.

[185]  S. Hori,et al.  Control of autoimmunity by naturally arising regulatory CD4+ T cells. , 2003, Advances in immunology.

[186]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[187]  T. Takken,et al.  Aerobic fitness in children with juvenile idiopathic arthritis: a systematic review. , 2002, The Journal of rheumatology.

[188]  P. Pelkonen,et al.  The influence of heredity for psoriasis on the ILAR classification of juvenile idiopathic arthritis. , 2002, The Journal of rheumatology.

[189]  N. Kamatani,et al.  Association between adult-onset Still's disease and interleukin-18 gene polymorphisms , 2002, Genes and Immunity.

[190]  W. Ollier,et al.  Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. , 2002, Arthritis and rheumatism.

[191]  P Woo,et al.  Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. , 2002, Rheumatology.

[192]  R. Burgos-Vargas,et al.  A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies , 2002, Annals of the rheumatic diseases.

[193]  R. Petty,et al.  The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[194]  A. Rosenberg.  Uveitis associated with childhood rheumatic diseases. , 2002, Current opinion in rheumatology.

[195]  M. Cheang,et al.  Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. , 2002, The Journal of rheumatology.

[196]  K. Miyata,et al.  Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al. , 2002, Arthritis and rheumatism.

[197]  K. Minden,et al.  Long-term outcome in patients with juvenile idiopathic arthritis. , 2002, Arthritis and rheumatism.

[198]  A. Ravelli.  Macrophage activation syndrome. , 2002, Current opinion in rheumatology.

[199]  W. Thomson,et al.  Genetic epidemiology: Juvenile idiopathic arthritis genetics - What's new? What's next? , 2002, Arthritis Research.

[200]  R. Burgos-Vargas.  The juvenile-onset spondyloarthritides. , 2002, Rheumatic diseases clinics of North America.

[201]  V. Pistoia,et al.  Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides. , 2002, The Journal of rheumatology.

[202]  K. Oen.  Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis. , 2002, Best practice & research. Clinical rheumatology.

[203]  P. Manners,et al.  Worldwide prevalence of juvenile arthritis why does it vary so much? , 2002, The Journal of rheumatology.

[204]  A. Martini,et al.  Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis. , 2002, Clinical and experimental rheumatology.

[205]  P. Czernichow,et al.  Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids. , 2002, The Journal of rheumatology.

[206]  R. Burgos-Vargas,et al.  The place of juvenile onset spondyloarthropathies in the Durban 1997 ILAR classification criteria of juvenile idiopathic arthritis. International League of Associations for Rheumatology. , 2002, The Journal of rheumatology.

[207]  P. Wolf,et al.  Sportfähigkeit nach Schulterarthroplastik , 2002 .

[208]  B. Dijkmans,et al.  Severe aortic regurgitation in RF positive polyarticular JIA , 2002, Annals of the rheumatic diseases.

[209]  A. Martini,et al.  Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. , 2002, Arthritis and rheumatism.

[210]  P. Dungl,et al.  [Knee joint synovectomy in treatment of juvenile idiopathic arthritis]. , 2002, Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca.

[211]  N. Ilowite.  Current treatment of juvenile rheumatoid arthritis. , 2002, Pediatrics.

[212]  P. Pelkonen,et al.  Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology. European League Against Rheumatism. , 2001, The Journal of rheumatology.

[213]  R. Merino,et al.  Evaluation of ILAR classification criteria for juvenile idiopathic arthritis in Spanish children. , 2001, The Journal of rheumatology.

[214]  P. Woo,et al.  Divergence in the degree of clonal expansions in inflammatory T cell subpopulations mirrors HLA-associated risk alleles in genetically and clinically distinct subtypes of childhood arthritis. , 2001, International immunology.

[215]  G L Freeman,et al.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. , 2001, Arthritis and rheumatism.

[216]  S. J. Lee,et al.  HLA-B27 positive juvenile arthritis with cardiac involvement preceding sacroiliac joint changes , 2001, Heart.

[217]  A. Prieur,et al.  Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. , 2001, Rheumatology.

[218]  T. Alonzi,et al.  Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. , 2001, Endocrinology.

[219]  R. Häfner,et al.  Evaluation of the ILAR criteria for juvenile idiopathic arthritis. , 2001, The Journal of rheumatology.

[220]  S. Sawhney,et al.  Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders , 2001, Archives of disease in childhood.

[221]  A. Reiff,et al.  Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis. , 2001, The Journal of rheumatology.

[222]  A. Reiff,et al.  Etanercept therapy in children with treatment-resistant uveitis. , 2001, Arthritis and rheumatism.

[223]  D. Glass,et al.  Chemokine Receptor CCR4 on CD4+ T Cells in Juvenile Rheumatoid Arthritis Synovial Fluid Defines a Subset of Cells with Increased IL-4:IFN-γ mRNA Ratios1 , 2001, The Journal of Immunology.

[224]  A. Prieur,et al.  Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. , 2001, The Journal of rheumatology.

[225]  R. Petty.  Growing pains: the ILAR classification of juvenile idiopathic arthritis. , 2001, The Journal of rheumatology.

[226]  J. Barrett,et al.  Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis , 2001 .

[227]  G. Boivin,et al.  Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice. , 2001, Arthritis and rheumatism.

[228]  T. Tanimoto,et al.  Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. , 2001, Arthritis and rheumatism.

[229]  C. J. Anderson,et al.  Possible role of antiidiotypes in the loss of anti-topoisomerase I antibodies: comment on the article by Kuwana et al. , 2001, Arthritis and rheumatism.

[230]  F. Fantini.  Classification of chronic arthritides of childhood (juvenile idiopathic arthritis): criticisms and suggestions to improve the efficacy of the Santiago-Durban criteria. , 2001, The Journal of rheumatology.

[231]  P. Czernichow,et al.  Linear growth in children suffering from juvenile idiopathic arthritis requiring steroid therapy: natural history and effects of growth hormone treatment on linear growth. , 2001, Journal of pediatric endocrinology & metabolism : JPEM.

[232]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[233]  M. Leirisalo-Repo,et al.  Magnitude of the genetic component in juvenile idiopathic arthritis , 2000, Annals of the rheumatic diseases.

[234]  M. Frosch,et al.  A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis. , 2000, The Journal of rheumatology.

[235]  D. Glass,et al.  Twins concordant for juvenile rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[236]  S D Thompson,et al.  Juvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairs. , 2000, Arthritis and rheumatism.

[237]  M. Brandi,et al.  Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. , 2000, Arthritis and rheumatism.

[238]  J. Coste,et al.  Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. , 2000, Arthritis and rheumatism.

[239]  A. Martini,et al.  Methotrexate in juvenile idiopathic arthritis: answers and questions. , 2000, The Journal of rheumatology.

[240]  S. Karademir,et al.  Left Ventricular Diastolic Functions in Juvenile Rheumatoid Arthritis , 2000, Pediatric Cardiology.

[241]  Andre Peeters,et al.  Etanercept in children with polyarticular juvenile rheumatoid arthritis , 2000 .

[242]  R. Petty,et al.  Comparison of criteria for the classification of childhood arthritis. , 2000, The Journal of rheumatology.

[243]  F. Riordan.  Use of unlabelled and off licence drugs in children , 2000, BMJ : British Medical Journal.

[244]  A. Martini,et al.  Use of unlabelled and off licence drugs in children. A European paediatric rule is needed to protect children. , 2000, BMJ.

[245]  Richard W. Martin,et al.  A PHASE III TRIAL OF ETANERCEPT vs METHOTREXATE (MTX) IN EARLY RHEUMATOID ARTHRITIS (ENBREL ERA TRIAL) , 2000 .

[246]  I. Foeldvari,et al.  Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology. , 2000, The Journal of rheumatology.

[247]  P. Woo,et al.  Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. , 2000, Arthritis and rheumatism.

[248]  H. Huppertz,et al.  Cardiac Manifestations in Patients with HLA B27-Associated Juvenile Arthritis , 2000, Pediatric Cardiology.

[249]  R. Cimaz,et al.  Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. , 2000, The Journal of rheumatology.

[250]  A. Schraml.  Die Synovektomie des Hüftgelenkes bei juveniler chronischer Arthritis , 2000 .

[251]  T. Sasazuki,et al.  Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes. , 1999, Arthritis and rheumatism.

[252]  D. Glass,et al.  Juvenile rheumatoid arthritis as a complex genetic trait. , 1999, Arthritis and rheumatism.

[253]  L. Schanberg,et al.  Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids. , 1999, Arthritis and rheumatism.

[254]  A. Martini,et al.  Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis. , 1999, Clinical and experimental rheumatology.

[255]  C. Wallace,et al.  On beyond methotrexate treatment of severe juvenile rheumatoid arthritis. , 1999, Clinical and experimental rheumatology.

[256]  B. Andersson-Gäre.  Juvenile arthritis - who gets it, where and when? : A review of current data on incidence and prevalence , 1999 .

[257]  N. Wulffraat,et al.  Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis , 1999, The Lancet.

[258]  J. Kremer,et al.  A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. , 1999, The New England journal of medicine.

[259]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[260]  M. Suarez‐Almazor,et al.  Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. , 1998, The Journal of rheumatology.

[261]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[262]  A. Fasth,et al.  Juvenile chronic arthritis in urban San José, Costa Rica: a 2 year prospective study. , 1998, The Journal of rheumatology.

[263]  P. Dent,et al.  Intra-articular corticosteroids in the treatment of juvenile rheumatoid arthritis. , 1998, Current opinion in rheumatology.

[264]  H. Hebestreit,et al.  Aerobic fitness and physical activity in patients with HLA-B27 positive juvenile spondyloarthropathy that is inactive or in remission. , 1998, The Journal of rheumatology.

[265]  A. Martini,et al.  Radiologic progression in patients with juvenile chronic arthritis treated with methotrexate. , 1998, The Journal of pediatrics.

[266]  D. Glass,et al.  Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. , 1998, The Journal of rheumatology.

[267]  S. Padeh,et al.  Intraarticular corticosteroid injection in the management of children with chronic arthritis. , 1998, Arthritis and rheumatism.

[268]  R. Wolfe,et al.  Severe aortic regurgitation with mechanical prosthetic valve replacement in pauciarticular juvenile rheumatoid arthritis. , 1998, The Journal of rheumatology.

[269]  A. Zwinderman,et al.  Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group. , 1998, Arthritis and rheumatism.

[270]  C. Wallace,et al.  The use of methotrexate in childhood rheumatic diseases. , 1998, Arthritis and rheumatism.

[271]  G. Kollias,et al.  Interleukin 6 Is Required for the Development of Collagen-induced Arthritis , 1998, The Journal of experimental medicine.

[272]  A. Martini,et al.  Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease? , 1998, The Journal of rheumatology.

[273]  A. Reiff,et al.  Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. , 1997, The Journal of rheumatology.

[274]  C. Rosé,et al.  The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study. , 1997, The Journal of rheumatology.

[275]  D. Sherry,et al.  Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[276]  A. Martini,et al.  Cytokines in juvenile rheumatoid arthritis. , 1997, Current opinion in rheumatology.

[277]  J. Jarvis,et al.  Juvenile rheumatoid arthritis in African Americans. , 1997, The Journal of rheumatology.

[278]  E. Tindall,et al.  Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. , 1997, The New England journal of medicine.

[279]  D. Felson,et al.  Preliminary definition of improvement in juvenile arthritis. , 1997, Arthritis and rheumatism.

[280]  A. Corti,et al.  Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis. , 1997, The Journal of rheumatology.

[281]  R. Petty,et al.  Clinical and therapeutic aspects of juvenile-onset spondyloarthropathies. , 1997, Current opinion in rheumatology.

[282]  F. Ghiotto,et al.  Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0‐type pattern of cytokine secretion irrespective of immunophenotype , 1997, Clinical and experimental immunology.

[283]  A. Corti,et al.  Soluble tumour necrosis factor receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritis. , 1997, British journal of rheumatology.

[284]  P. Woo,et al.  Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2). , 1997, British journal of rheumatology.

[285]  M. Okuni,et al.  Clinical analysis of 570 cases with juvenile rheumatoid arthritis: Results of a nationwide retrospective survey in Japan , 1997, Acta paediatrica Japonica : Overseas edition.

[286]  R. Petty,et al.  Rheumatoid factor positive, oligoarticular onset juvenile rheumatoid arthritis. , 1997, The Journal of rheumatology.

[287]  G. Ciliberto,et al.  Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. , 1997, The Journal of clinical investigation.

[288]  M. Cheang,et al.  Epidemiology of chronic arthritis in childhood. , 1996, Seminars in arthritis and rheumatism.

[289]  D. Witte,et al.  Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis. , 1996, The Journal of rheumatology.

[290]  E. Haddad,et al.  Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. , 1996, The Journal of pediatrics.

[291]  M. Passo,et al.  Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. , 1996, The Journal of pediatrics.

[292]  E. Lander.  The New Genomics: Global Views of Biology , 1996, Science.

[293]  D. Glass,et al.  Patterns of expression of tumor necrosis factor α, tumor necrosis factor β, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy , 1996 .

[294]  R. Häfner,et al.  Psoriatic arthritis in children. , 1996, Current opinion in rheumatology.

[295]  P. Manners,et al.  Prevalence of juvenile chronic arthritis in a population of 12-year-old children in urban Australia. , 1996, Pediatrics.

[296]  M. Cazzola,et al.  Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. , 1996, Blood.

[297]  L. Joosten,et al.  Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra. , 1996 .

[298]  A. Martini,et al.  Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. , 1996, The Journal of pediatrics.

[299]  M. De Vos,et al.  The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. , 1995, The Journal of rheumatology.

[300]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[301]  J. Jarvis,et al.  Composition and biological behaviour of immune complexes isolated from synovial fluid of patients with juvenile rheumatoid arthritis (JRA) , 1995, Clinical and experimental immunology.

[302]  M. Pieper,et al.  [Arthroscopic synovectomy of the knee joint in chronic juvenile arthritis]. , 1995, Zeitschrift fur Rheumatologie.

[303]  J. Smallhorn,et al.  Prevalence of cardiac manifestations of juvenile ankylosing spondylitis. , 1995, The American journal of cardiology.

[304]  A. Reiff,et al.  High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. , 1995, Clinical and experimental rheumatology.

[305]  G. Ciliberto,et al.  Rational design of a receptor super‐antagonist of human interleukin‐6. , 1994, The EMBO journal.

[306]  M. Cazzola,et al.  Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis , 1994, The Lancet.

[307]  R. Petty.  Juvenile psoriatic arthritis, or juvenile arthritis with psoriasis? , 1994, Clinical and experimental rheumatology.

[308]  Prieur Am,et al.  Macrophage activation syndrome in rheumatic diseases in children , 1994 .

[309]  B. Ansell.  Juvenile psoriatic arthritis. , 1994, Bailliere's clinical rheumatology.

[310]  U. Andersson,et al.  Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis , 1994, Clinical and experimental immunology.

[311]  S. Albani,et al.  Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. , 1994, The Journal of clinical investigation.

[312]  T. Southwood,et al.  Arthritis in Children and Adolescents , 1994 .

[313]  G. Berglund,et al.  Ultrasound-determined intima-media thickness and atherosclerosis. Direct and indirect validation. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[314]  O. Söylemezoğlu,et al.  Dilated cardiomyopathy in juvenile chronic arthritis. , 1994, Scandinavian journal of rheumatology.

[315]  A. Poznanski,et al.  Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis. , 1993, Arthritis and rheumatism.

[316]  M. De Vos,et al.  A prospective study of patients with spondyloarthropathy with special reference to HLA-B27 and to gut histology. , 1993, The Journal of rheumatology.

[317]  J. Saldanha,et al.  Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. , 1993, Cancer Research.

[318]  D. Sherry,et al.  Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis. , 1992, The Journal of rheumatology.

[319]  R. Petty,et al.  SEA syndrome revisited: a longterm followup of children with a syndrome of seronegative enthesopathy and arthropathy. , 1992, The Journal of rheumatology.

[320]  W. van Eden,et al.  Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis , 1992, The Journal of experimental medicine.

[321]  E. Protas,et al.  Exercise response in children with and without juvenile rheumatoid arthritis: a case-comparison study. , 1992, Physical therapy.

[322]  B. Heimkes,et al.  [Results of late synovectomy of the hip in juvenile chronic arthritis]. , 1992, Zeitschrift fur Rheumatologie.

[323]  J. Cassidy,et al.  Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. , 1992, The New England journal of medicine.

[324]  C. Wallace,et al.  Dismantling the pyramid. , 1992, The Journal of rheumatology. Supplement.

[325]  E. Giannini,et al.  Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritis--preliminary results of a longterm study. , 1992, The Journal of rheumatology.

[326]  M. Ferraz,et al.  Symptomatic cardiac involvement in juvenile rheumatoid arthritis. , 1992, International journal of cardiology.

[327]  A. Martini,et al.  Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. , 1991, Arthritis and rheumatism.

[328]  L. Sawyer,et al.  Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. , 1990, The Journal of pediatrics.

[329]  J. Heyd,et al.  Early occurrence of aortic valve regurgitation in a youth with systemic-onset juvenile rheumatoid arthritis. , 1990, The American journal of medicine.

[330]  R. Petty,et al.  Psoriatic arthritis in children. , 1989, Arthritis and rheumatism.

[331]  M. Bond,et al.  Detection and monitoring of asymptomatic atherosclerosis in clinical trials. , 1989, The American journal of medicine.

[332]  Nelson Am,et al.  The frequency of juvenile arthritis. , 1988 .

[333]  L. E. Clemens,et al.  A crossover study of naproxen, diclofenac and tolmetin in seronegative juvenile chronic arthritis. , 1988, Clinical and experimental rheumatology.

[334]  J. Cassidy,et al.  The frequency of juvenile arthritis. , 1988, The Journal of rheumatology.

[335]  L. D'Orsogna,et al.  Aortic valve insufficiency and coronary artery narrowing in a child with polyarticular juvenile rheumatoid arthritis. , 1988, The Journal of rheumatology.

[336]  B. Ansell,et al.  Juvenile chronic arthritis. , 1986, Scandinavian journal of rheumatology. Supplement.

[337]  M. Hall,et al.  Aortic incompetence in pauciarticular juvenile chronic arthritis. , 1986, Archives of disease in childhood.

[338]  E. Schned,et al.  Epidemiology of juvenile arthritis in Rochester, Minnesota. , 1985, Arthritis and rheumatism.

[339]  al-Hussaini Mk,et al.  Cardiac tamponade in systemic juvenile rheumatoid arthritis requiring emergency pericardiectomy. , 1984 .

[340]  B. Ansell,et al.  The management of chronic arthritis of children. , 1983, The Journal of bone and joint surgery. British volume.

[341]  W. O'Fallon,et al.  The epidemiology of juvenile arthritis in Rochester, Minnesota 1960-1979. , 1983, Arthritis and rheumatism.

[342]  L. E. Clemens,et al.  HLA studies in IgM rheumatoid-factor-positive arthritis of childhood. , 1983, Annals of the rheumatic diseases.

[343]  F. Waldman,et al.  Severe aortic insufficiency in juvenile chronic arthritis. , 1983, The American journal of medicine.

[344]  G. Björkhem,et al.  CARDIAC INVOLVEMENT IN JUVENILE RHEUMATOID ARTHRITIS , 1983, Acta paediatrica Scandinavica.

[345]  L. Lidgren,et al.  Synovectomy of the hip in juvenile chronic arthritis. , 1982, The Journal of bone and joint surgery. British volume.

[346]  R. Petty,et al.  Textbook of pediatric rheumatology , 1982 .

[347]  B. Cohlan,et al.  Pericarditis and cardiac tamponade in juvenile rheumatoid arthritis. , 1981, Pediatrics.

[348]  B. Ansell,et al.  Aortic regurgitation in seropositive juvenile arthritis. , 1981, Annals of the rheumatic diseases.

[349]  A. Larsen,et al.  Radiographic Evaluation of Rheumatoid Arthritis and Related Conditions by Standard Reference Films , 1977, Acta radiologica: diagnosis.

[350]  J. French,et al.  Myocarditis in juvenile rheumatoid arthritis. , 1977, American journal of diseases of children.

[351]  N. Gschwend,et al.  Die operative Behandlung der chronischen Polyarthritis , 1977 .

[352]  J. Dequeker,et al.  Arthritis and heart lesions. A study of 25 cases with pericarditis or valvular lesions associated to inflammatory joint disease. , 1976, Acta cardiologica.

[353]  O. Steinbrocker,et al.  Therapeutic criteria in rheumatoid arthritis. , 1949, Journal of the American Medical Association.

[354]  G. Still.  On a form of chronic joint disease in children , 1941, Archives of disease in childhood.